Sort   by:  
 Page size 
UnknownPrognosis after curative resection of non-metastatic pancreatic neuroendocrine tumors: a retrospective tertiary center study
Not available
S-EPMC11574156 | biostudies-literature
TranscriptomicsLong-term Exposure to Sorafenib of Liver Cancer Cells Induces Resistance with Epithelial-to-Mesenchymal Transition, Increased Invasion and Risk of Rebound Growth
Sorafenib leads to a survival benefit in patients with advanced hepatocellular carcinoma but its use is hampered by the occurrence of drug resistance. To investigate the molecular mechanisms involved we developed five resistant human liver cell lines in which we studied morphology, gene expression a...
ORGANISM(S): Homo sapiens 
2016-03-14 | E-GEOD-62813 | biostudies-arrayexpress
TranscriptomicsCombining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.
Objective: Insights about differences in tumor vasculature and how it reacts to VEGF inhibition is limited, but nevertheless of major relevance to anti-angiogenic therapy. In this study we therefore characterize the effect of bevacizumab combined with chemoradiotherapy (CRT), and explore molecular a...
ORGANISM(S): Homo sapiens 
2016-08-02 | E-GEOD-60331 | biostudies-arrayexpress
Sort   by:  
 Page size